Cancer News and Research

Latest Cancer News and Research

Researchers analyze immune properties of ancient human DNA

Could remnants of DNA from a now-extinct human subspecies known as the Denisovans help boost the immune functions of modern humans?

16 Jun 2020

New model predicts patients’ likelihood of testing positive for COVID-19

Cleveland Clinic researchers have developed the world's first risk prediction model for healthcare providers to forecast an individual patient's likelihood of testing positive for COVID-19 as well as their outcomes from the disease.

16 Jun 2020

Multilevel interventions improve overall rate of HPV vaccinations

New research from Boston Medical Center shows that providing education and training to pediatric and family medicine providers about the importance of human papillomavirus vaccines, in tandem with healthcare systems changes including starting an HPV vaccination series before the age of 11, improves the overall rate of HPV vaccinations among adolescent patients.

15 Jun 2020

Apotex recalls some Metformin batches due to possible carcinogen

Metformin, a prescription drug for people with type II diabetes, helps maintain blood glucose levels. Apotex Inc., a Canadian pharmaceutical corporation, is voluntarily recalling some batches of its metformin drug, sold under the brand name APO-Metformin ER (extended-release).

15 Jun 2020

Electronic health information exchange increases disease reporting and completeness of information

Disease tracking is an important area of focus for health departments in the midst of the COVID-19 pandemic.

15 Jun 2020

NIH launches a centralized, secure enclave to store and study COVID-19 patient data

The National Institutes of Health has launched a centralized, secure enclave to store and study vast amounts of medical record data from people diagnosed with coronavirus disease across the country.

15 Jun 2020

University of Colorado partners with MedTech entrepreneurs to form Preview Medical, Inc

The University of Colorado Anschutz Medical Campus, led by CU Innovations, has partnered with serial MedTech entrepreneurs Jonathan Gasson and Sharon Lake to form PreView Medical, Inc. PreView's clinically proven technology focuses on the diagnosis and treatment optimization of prostate cancer.

15 Jun 2020

Study finds drivers of healthy gut maintenance

Researchers at the Francis Crick Institute have found two genes that regulate the differentiation of stem cells in the small intestine, offering valuable insight into how the body develops and maintains a healthy gut.

15 Jun 2020

Temple researchers receive $1.77M grant to explore therapy for cocaine addiction

Cocaine is a highly addictive drug - some people are unable to walk away from it after just one use. And once addicted, users can lose control of their lives.

15 Jun 2020

Dante Labs, Cambridge Cancer Genomics and Nonacus collaborate to provide precision oncology at scale

Dante Labs, Cambridge Cancer Genomics, and Nonacus, today announced that they have signed a collaboration agreement.

15 Jun 2020

Tumor-resident T cell levels underlie improved survival in throat cancer patients

Research led by the Centenary Institute has discovered that immune cells accumulating within the tumor environment, called tumour-resident T cells, are a critical determinant in survival rates of patients suffering from throat cancer.

15 Jun 2020

Hologram technology may help doctors deliver targeted liver cancer treatments

Data from one of the first clinical uses of augmented reality guidance with electromagnetically tracked tools shows that the technology may help doctors quickly, safely, and accurately deliver targeted liver cancer treatments, according to a research abstract presented during a virtual session of the Society of Interventional Radiology's 2020 Annual Scientific Meeting on June 14.

15 Jun 2020

New treatment may improve the quality of life for patients with mesothelioma

A novel treatment for advanced mesothelioma is safe and effective and may improve the quality of life for patients who have few treatment options, according to a research abstract presented during a virtual session of the Society of Interventional Radiology's 2020 Annual Scientific Meeting on June 14.

15 Jun 2020

Chimeric reference standards for validating controls in SARS-CoV-2 tests

A preliminary study by researchers from the Garvan Institute of Medical Research and the University of New South Wales and published on the preprint server bioRxiv in June 2020 reports the use of chimeric design to produced reference standards for diagnostic tests. This could allow a highly flexible approach to the development of different genetic features in the same test, even for organisms that are not directly related.

15 Jun 2020

Study reveals protein responsible for vulnerability in cancer cells

A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

14 Jun 2020

RCSI scientists develop new biomaterial with potential to accelerate bone regeneration

Scientists at RCSI University of Medicine and Health Sciences have developed a new biomaterial that has the potential to accelerate bone regeneration by promoting an immune response that encourages repair and lowers the risk of inflammation.

12 Jun 2020

Study shows how combining two drugs may be an effective treatment for HLH

Scientists at St. Jude Children's Research Hospital, UCSF Benioff Children's Hospitals and Baylor College of Medicine are investigating how to best treat hemophagocytic lymphohistiocytosis (HLH), a rare immune disorder.

12 Jun 2020

Damon Runyon Cancer Research Foundation awards $3.2 million to early-career physician-scientists

The Damon Runyon Cancer Research Foundation has named four new Damon Runyon Clinical Investigators.

12 Jun 2020

Study finds link between high levels of dietary AGEs and breast cancer risk

Hollings Cancer Center researchers at the Medical University of South Carolina and colleagues assessed the connection between dietary advanced glycation end products and breast cancer risk in a study first published online March 2020 in Cancer Prevention Research.

12 Jun 2020

Prodigiosin-based nanoformulation selectively disrupts cancer cells

Together with colleagues from the University of Palermo, KFU employees offer a nano preparation based on biocompatible halloysite nanotubes and bacterial pigment prodigiosin; the latter is known to selectively disrupt cancer cells without damaging the healthy ones.

12 Jun 2020

Cancer News and Research

Latest Cancer News and Research

Researchers analyze immune properties of ancient human DNA

New model predicts patients’ likelihood of testing positive for COVID-19

Multilevel interventions improve overall rate of HPV vaccinations

Apotex recalls some Metformin batches due to possible carcinogen

Electronic health information exchange increases disease reporting and completeness of information

NIH launches a centralized, secure enclave to store and study COVID-19 patient data

University of Colorado partners with MedTech entrepreneurs to form Preview Medical, Inc

Study finds drivers of healthy gut maintenance

Temple researchers receive $1.77M grant to explore therapy for cocaine addiction

Dante Labs, Cambridge Cancer Genomics and Nonacus collaborate to provide precision oncology at scale

Tumor-resident T cell levels underlie improved survival in throat cancer patients

Hologram technology may help doctors deliver targeted liver cancer treatments

New treatment may improve the quality of life for patients with mesothelioma

Chimeric reference standards for validating controls in SARS-CoV-2 tests

Study reveals protein responsible for vulnerability in cancer cells

RCSI scientists develop new biomaterial with potential to accelerate bone regeneration

Study shows how combining two drugs may be an effective treatment for HLH

Damon Runyon Cancer Research Foundation awards $3.2 million to early-career physician-scientists

Study finds link between high levels of dietary AGEs and breast cancer risk

Prodigiosin-based nanoformulation selectively disrupts cancer cells

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in